期刊文献+

利拉鲁肽结合二甲双胍治疗2型糖尿病临床分析

原文传递
导出
摘要 目的探讨利拉鲁肽结合二甲双胍用于2型糖尿病治疗临床疗效。方法选取我院收治的80例2型糖尿病病人作为研究对象,并分为对照组以及研究组。对照组采用盐酸二甲双胍片进行治疗,研究组患者采用利拉鲁肽结合二甲双胍进行治疗。观察对比两组的疗效及不良反应发生情况。结果两组患者治疗后在BMI、PBG、FPG、2hPG等四项指标上较治疗前均有显著下降,但是研究组患者其下降幅度较对照组治疗后更为显著,对比差异具有统计学意义(P <0.05);研究组患者不良反应发生率显著低于对照组患者,对比差异具有统计学意义(P<0.05)。结论利拉鲁肽结合二甲双胍对2型糖尿病病人有不错的临床疗效,有利于降低患者不良反应发生率。
作者 刘景云
出处 《首都食品与医药》 2019年第1期53-53,共1页 Capital Food Medicine
  • 相关文献

参考文献2

二级参考文献18

  • 1Whiting DR,Guariguata L,Weil C,et al.IDF diabetes ailas:global estimates of the prevalence of diabetes for 2011 and 2030[J].Diabetes Res Clin Pract,2011,94:311-321.
  • 2Dharmalingam M,Sriram U,Baruah MP.Liraglutide:a review of its therapeutic use as a once daily GLP-1 analog for the management of type 2 diabetes mellitus[J].Indian J Endocrinol Metab,2011,15:9-17.
  • 3Inzucchi SE,Bergenstal RM,Buse JB,et al.Management of hyperglycemia in type 2 diabetes:a patient-centered approach:position statement of the american diabetes association(ADA)and the European Association for the Study of Diabetes(EASD)[J].Diabetologia,2012,55:1577-1596.
  • 4Marre M,Shaw J,Brandle M,et al.Liraglutide,a once-daily human GLP-1 analogue,added to a sulphonylurea over 26 weeks produces greater improvements in glycaemic and weight control compared with adding rosiglitazone or placebo in subjects with Type 2 diabetes(LEAD-1 SU)[J].Diabetic Medicine,2009,26(3):268-278.
  • 5Nauck M,Frid A,Hermansen K,et al.Efficacy and safety comparison of liraglutide,glimepiride and placebo,all in combi-nation with metformin in type 2 diabetes the LEAD(liraglutide effect and action in diabetes)-2 study[J].Diabetes Care,2009,32(1):84-90.
  • 6Garber A,Henry R,Ratner R,et al.Liraglutide versus glimepiride monotherapy for type 2 diabetes(LEAD-3 Mono):a randomized,52 week,phaseⅢ,double blind,parallel treatment trial[J].Lancet,2008,373(9662):473-481.
  • 7Zinman B,Gerich J,Bush JB,et al.Efficacy and safety of the human glucagon-like peptide-1 analog liraglutide in combi-nation with metformin and thiazolidinedione in patients with type 2 diabetes(LEAD-4 Met+TZD)[J].Diabetes Care,2009,32(7):1224-1230.
  • 8Russell-Jones D,Vaag A,Schmitz O,et al.Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes millitus(LEAD-5 met+SU):a randomised conerolled trial[J].Diabetologia,2009,52(10):2046-2055.
  • 9Bush JB,Rosenstock J,Sesti G,et al.Lirglutide once a day versus exenatide twice a day for type 2 diabetes:a 26-week randomized,parallel group,multinational,open label trial(LEAD-6)[J].Lancet,2009,374(9683):39-47.
  • 10Baggio LL,Drucker DJ.Biology of incretins:GLP-1 and GIP[J].Gastroenterology,2007,132:2131-2157.

共引文献59

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部